395 related articles for article (PubMed ID: 5539694)
1. [Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa?].
Gauthier G; de Ajuriaguerra J; Geissbuhler F; Simona B; Constantinidis J; Yanniotis G; Krassoievitch M; Eisenring JJ; Tissot R
Presse Med (1893); 1971 Jan; 79(3):91-2. PubMed ID: 5539694
[No Abstract] [Full Text] [Related]
2. [L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].
Görlich J; Markus E
Dtsch Med Wochenschr; 1972 Aug; 97(34):1246-8. PubMed ID: 5048316
[No Abstract] [Full Text] [Related]
3. [Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].
Steinhäusl H
Wien Med Wochenschr; 1973 Jun; 123(26):433-5. PubMed ID: 4578743
[No Abstract] [Full Text] [Related]
4. [Quantitative rigor determination in Parkinson's disease. Myo-integration for therapy control of L-Dopa in combination with a decarboxylase inhibitor (Ro 8-0576)].
Gehlen W; Eisenlohr JJ
Nervenarzt; 1974 Jan; 45(2):22-9. PubMed ID: 4601993
[No Abstract] [Full Text] [Related]
5. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
Ferel D
Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
[No Abstract] [Full Text] [Related]
6. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].
Tissot R; de Ajuriaguerra J
Nouv Presse Med; 1973 Feb; 2(5):315-6. PubMed ID: 4686226
[No Abstract] [Full Text] [Related]
7. [Dopa and decarboxylase inhibitors in Parkinson's disease].
Pakkenberg H
Ugeskr Laeger; 1974 Feb; 136(7):377. PubMed ID: 4821980
[No Abstract] [Full Text] [Related]
8. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
Guillard A
Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191
[No Abstract] [Full Text] [Related]
9. [Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects].
Geissbuhler F; Eisenring JJ; Friedli P; Bartholini G; Tissot R
Encephale; 1972; 61(2):127-48. PubMed ID: 4634903
[No Abstract] [Full Text] [Related]
10. [Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].
Tissot R; Bartholini G; Constantinidis J; Eisenring JJ; Geissbühler F; Yanniotis G; de Ajuriaguerra J
Schweiz Med Wochenschr; 1973 Oct; 103(42):1466-74. PubMed ID: 4750149
[No Abstract] [Full Text] [Related]
11. [Cardiovascular effects of L-dopa and decarboxylase inhibitor on patients with Parkinson's disease].
Desjacques P; Moret P; Gauthier G
Schweiz Med Wochenschr; 1973 Dec; 103(50):1783-5. PubMed ID: 4129257
[No Abstract] [Full Text] [Related]
12. [Therapy of parkinsonism using a combination of L-dopa and decarboxylase inhibitor].
Völler GW; Muschard F
Med Welt; 1973 Apr; 24(17):705-7. PubMed ID: 4750934
[No Abstract] [Full Text] [Related]
13. [Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)].
Tissot R; Gaillard JM; Guggisberg M; Gauthier G; De Ajuriaguerra J
Neurol Neurocir Psiquiatr; 1969; 10(1):1-25. PubMed ID: 5406970
[No Abstract] [Full Text] [Related]
14. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
Andrews CJ; Somerville B
Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
[No Abstract] [Full Text] [Related]
15. [Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].
Siegfried J; Klaiber R; Perret E; Ziegler WH
Dtsch Med Wochenschr; 1969 Dec; 94(52):2678-81. PubMed ID: 4903342
[No Abstract] [Full Text] [Related]
16. [Treatment of Parkinson's disease: L-dopa or stereotaxic technics?].
Krayenbuhl H; Siegfried J
Neurochirurgie; 1970; 16(1):71-6. PubMed ID: 4911157
[No Abstract] [Full Text] [Related]
17. [Therapeutic association of L-dopa and an inhibitor of peripheral decarboxylase in Parkinsonism. Preliminary results].
De Divitiis E; Cerillo A; Tata MR; Decina A
Acta Neurol (Napoli); 1973; 28(2):208-12. PubMed ID: 4709076
[No Abstract] [Full Text] [Related]
18. [Effect of the combined treatment of Parkinson patients with L-Dopa and a decarboxylase inhibitor (Ro4-4602). Quantitative analysis of bradykinesia by means of reaction time measurements].
Kaufmann W; Butz P; Wiesendanger M
Dtsch Z Nervenheilkd; 1970; 197(1):85-100. PubMed ID: 5522871
[No Abstract] [Full Text] [Related]
19. [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].
Stammler A; Vielhaber K
Fortschr Neurol Psychiatr Grenzgeb; 1972 Oct; 40(10):564-8. PubMed ID: 4565521
[No Abstract] [Full Text] [Related]
20. [Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor].
Fischer PA; Schneider E; Jacobi P; Maxion H
Med Welt; 1973 Nov; 24(45):1742-6. PubMed ID: 4768206
[No Abstract] [Full Text] [Related]
[Next] [New Search]